Study | Field strength | Num. of TEs | Num. of plaques | Location | LRNC [ms] | Fibrous tissue [ms] | Intima & media [ms] | Ref. |
---|---|---|---|---|---|---|---|---|
in-vivo | 3 T | 7 | 15 | carotid | 37 ± 5 | 56 ± 9 | 54 ± 13 | *This study |
in-vivo | 1.5 T | 2 | 7 | carotid | 28 ± 6 | 51 ± 10 | 48 ± 7 | [16] |
ex-vivo | 1.5 T | 2 | 7 | carotid | 31 ± 5 | 51 ± 9 | 52 ± 7 | [16] |
ex-vivo | 1.5 T | 8 | 10 | carotid | 47 ± 14 | 60 ± 13 | 67 ± 23 | [17] |
ex-vivo | 1.5 T | 4 | 10 | carotid | 84 ± 41 | 95 ± 32 | 60 ± 6 | [18] |
ex-vivo | 9.4Â T | 7 | 3 | carotid | 35-49 | 48-60 | 72-76 | [19] |
ex-vivo | 4.7 T | 4 | 7 | coronary | 31 ± 7 | 55 ± 11 | 50 ± 10 | [20] |
ex-vivo | 1.5 T | 10 | 8 | various | 55 ± 3 | 79 ± 4 | 81 ± 3 | [21] |
ex-vivo | 4.7 T | 10 | 8 | various | 50 ± 3 | 63 ± 1 | 65 ± 2 | [21] |
ex-vivo | 9.4 T | 20 | 8 | various | 20 ± 3 | 30 ± 2 | 30 ± 3 | [21] |
ex-vivo | 1.5 T | 32 | 13 | various | < 20 | 100-200 | 68 ± 10 | [22] |
ex-vivo | 3 T | 7 | 14 | aorta/iliac | 54 ± 3 | 89 ± 6 | 76 ± 9 | [23] |